Anda di sini
Formulari Ubat KKM (FUKKM)
| # | Generic Name | MDC | Category | Indications | Pres. Restrictions | Dosage |
|---|---|---|---|---|---|---|
| 61 | Amino Acids & Glucose with Electrolytes Injection | B05BA10-910-P30-03-XXX | A | Source of amino acids, carbohydrate and electrolytes in patients needing IV nutrition | None | Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day, carbohydrate 4-6 g/kg/day |
| 62 | Amino Acids Injection | B05BA01-910-P30-01-XXX | A | Source of amino acids in patients needing IV nutrition | None | Dose to be individualised. ADULT usually 500-2000 ml by IV. ADULT usual requirement for amino acid: 1-2 g/kg/day |
| 63 | Amino Acids with Electrolytes Injection | B05BA10-910-P30-02-XXX | A | Source of amino acids and electrolytes in patients needing IV nutrition | None | Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day |
| 64 | Amino Acids, Glucose and Lipid with Electrolytes Injection | B05BA10-910-P30-01-XXX | A | Source of amino acids, carbohydrate, lipid and electrolytes in patients needing IV nutrition | None | Dose to be individualised. ADULT: 500 - 2000 ml daily given by IV. ADULT usual requirement for amino acid 1-2 g/kg/ day, carbohydrate 4-6 g/kg/day, lipid 2-3 g/kg/day |
| 65 | Amino Acids, Glucose and Lipid without Electrolytes Injection | B05BA10-910-P30-04-XXX | A | Source of amino acids and carbohydrate in patients needing IV nutrition. | None | ADULT usual requirement for amino acid 1-2 g/kg/ day, carbohydrate 4-6 g/kg/day, lipid 2-3 g/kg/day. Dosing is individualised and according to product insert/protocol. |
| 66 | Aminophylline 25mg/ml Injection | R03DA05-000-P30-01-XXX | B | Reversible airways obstruction, acute severe brochospasm | None | Adult: Loading dose: 6 mg/kg (ideal body weight) or 250-500 mg (25 mg/ml) by slow inj or infusion over 20-30 min. Maintenance infusion dose: 0.5 mg/kg/hr. Max rate: 25 mg/min. Children: 6 months and over (if not previously on theophylline): Loading dose: 6mg/kg. Maintenance dose: 6 mth-9 yr: 1 mg/kg/hr and 10-16 yr: 0.8 mg/kg/hr. Dosing is individualised and according to product insert/protocol. |
| 67 | Amiodarone 200 mg Tablet | C01BD01-110-T10-01-XXX | A* | Arrhythmias | None | 200 mg 3 times daily for 1 week, then reduced to 200 mg twice daily for another week. Maintenance dose, usually 200 mg daily or the minimum required to control the arrhythmia. Dosing is according to product insert / protocol. |
| 68 | Amiodarone 50 mg/ml Injection | C01BD01-110-P30-01-XXX | A*, A/KK | Category A*: i) Arrhythmias ii) Cardiopulmonary resuscitation of shock-resistant ventricular fibrillation in cardiac arrest Category A/KK: Ventricular arrythmia (ventricular tachycardia and ventricular fibrillation) | Category A*: None Category A/KK: Use only for emergency cases in health clinic with Medical Officers (MO) upon consultation with Family Medicine Specialist (FMS) | i) Initial: 5mg/kg over 20-120minutes Maintenance: 10-20mg/kg/24hr Max. dose: 1.2g/24hr. ii) Initial: 300mg or 5mg/kg rapid Additional 150mg if condition persists. Dosing is according to product insert / protocol. |
| 69 | Amisulpride 100mg Tablet | N05AL05-000-T10-01-XXX | A* | Treatment of psychoses, particularly acute or chronic schizophrenia disorders characterized by positive symptoms(e.g. delusion, hallucinations, thought disorders) and/or negative symptoms(e.g. blunted emotions, emotional and social withdrawal) including when the negative symptoms predominate | None | Predominantly negative episodes: 50-300 mg once daily adjusted according to the patient's response. Mixed episodes with positive and negative symptoms: 400-800 mg/day in 2 divided doses adjusted according to the patient's response. Should be taken on an empty stomach (Preferably taken before meals) |
| 70 | Amisulpride 400mg Tablet | N05AL05-000-T10-02-XXX | A* | Treatment of psychoses, particularly acute or chronic schizophrenia disorders characterized by positive symptoms(e.g. delusion, hallucinations, thought disorders) and/or negative symptoms(e.g. blunted emotions, emotional and social withdrawal) including when the negative symptoms predominate | None | Predominantly negative episodes: 50-300 mg once daily adjusted according to the patient's response. Mixed episodes with positive and negative symptoms: 400-800 mg/day in 2 divided doses adjusted according to the patient's response. Should be taken on an empty stomach (Preferably taken before meals) |
| 71 | Amitriptyline HCl 25 mg Tablet | N06AA09-110-T10-01-XXX | B | i) Depression ii) Nocturnal enuresis where organic pathology has been excluded | None | i) Initial: 25mg 3 times a day in the evening Increase gradually in the late evening or at bedtime if necessary up to a maximum of 150mg per day Hospitalised patient: 100mg per day Increase gradually to 200-300mg per day ii) CHILD 6 YEARS AND UNDER: 10mg at bedtime CHILD OVER 6 YEARS Initial: 10mg at bedtime Increase gradually if necessary up to a maximum of 25mg at bedtime Not recommended for treatment of depression in children under 12 years of age. Dosing is individualised and according to product insert/ protocol. |
| 72 | Amlodipine 10 mg and Valsartan 160 mg Tablet | C09DB01-935-T10-03-XXX | A/KK | Essential hypertension in patients whose blood pressure is not adequately controlled by monotherapy | None | Doses range from amlodipine besylate 5 mg/valsartan 160 mg to amlodipine besylate 10 mg/valsartan 320 mg ORALLY once daily, with dose titration occurring every 1 to 2 weeks if necessary. MAX amlodipine besylate 10 mg/valsartan 320 mg |
| 73 | Amlodipine 10 mg Tablet | C08CA01-000-T10-02-XXX | B | Hypertension | None | 5 mg once daily. Max: 10 mg once daily |
| 74 | Amlodipine 5 mg and Valsartan 160 mg Tablet | C09DB01-935-T10-02-XXX | A/KK | Essential hypertension in patients whose blood pressure is not adequately controlled by monotherapy | None | Doses range from amlodipine besylate 5 mg/valsartan 160 mg to amlodipine besylate 10 mg/valsartan 320 mg ORALLY once daily, with dose titration occurring every 1 to 2 weeks if necessary. MAX amlodipine besylate 10 mg/valsartan 320 mg |
| 75 | Amlodipine 5 mg Tablet | C08CA01-000-T10-01-XXX | B | Hypertension | None | 5 mg once daily. Max: 10 mg once daily |
| 76 | Amorolfine 5% Nail Lacquer | D01AE16-110-L50-01-XXX | A* | Fungal nail infections | None | Apply to affected nail once or sometimes twice a week after filling and cleansing, allow to dry, treat finger nail for 6 months, toe nail for 9 - 12 months (review at intervals of 3 months) |
| 77 | Amoxicillin (Amoxycillin) & Clavulanate 228 mg/5 ml Syrup | J01CR02-961-F21-02-XXX | A/KK | Infections caused by susceptible organisms | None | Mild to Moderate infection: 25mg/kg/day (based on Amoxicillin dose) in 2 divided dose. Severe infection: 45mg/kg/day (based on Amoxicillin dose) in 2 divided dose |
| 78 | Amoxicillin (Amoxycillin) 1g & Clavulanate 200mg Injection | J01CR02-961-P40-02-XXX | A | Infections caused by susceptible organisms. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection & osteomyelitis | None | CHILD less than 3 months: 30mg/kg 12 hourly. 3 months - 12 years: 30mg/kg 6 - 8 hourly. ADULT: 1.2 g by IV or intermittent infusion 6 - 8 hourly |
| 79 | Amoxicillin (Amoxycillin) 250mg Capsule | J01CA04-012-C10-01-XXX | B | Infections caused by susceptible strains of gram positive and gram negative organisms | None | ADULT: 250 - 500 mg 3 times daily. CHILD: 20 - 40 mg/kg/day in divided doses 8 hourly |
| 80 | Amoxicillin (Amoxycillin) 250mg/5mL Oral Solution | J01CA04-012-L80-01-XXX | B | Infections caused by susceptible strains of gram positive and gram negative organisms | None | CHILD less than 10 years: 125 - 250 mg 8 hourly. CHILD less than 20 kg: 20 - 40 mg/kg/day in 3 - 4 divided doses |
| 81 | Amoxicillin (Amoxycillin) 500mg & Clavulanate 125mg Tablet | J01CR02-961-T10-02-XXX | A/KK | Infections due to beta-lactamase producing strain where amoxicillin alone is not appropriate. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection & osteomyelitis | None | ADULT & CHILD more than 12 years: Mild to moderate infections: 625 mg twice daily. |
| 82 | Amoxicillin (Amoxycillin) 500mg and Clavulanate 100mg Injection | J01CR02-961-P40-01-XXX | A | Infections caused by susceptible organisms. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection and osteomyelitis | None | CHILD less than 3 months: 30mg/kg 12 hourly. 3 months - 12 years: 30 mg/kg 6 - 8 hourly. ADULT: 1.2 g by IV or intermittent infusion 6 - 8 hourly |
| 83 | Amoxicillin (Amoxycillin) 500mg Capsule | J01CA04-012-C10-02-XXX | B | Infections caused by susceptible strains of gram positive and gram negative organisms | None | ADULT: 250 - 500 mg 3 times daily. CHILD: 20 - 40 mg/kg/day in divided doses 8 hourly |
| 84 | Amoxicillin (Amoxycillin) Trihydrate 125 mg/5 ml Syrup | J01CA04-012-F10-01-XXX | B | Infections caused by susceptible strains of gram positive and gram negative organisms | None | CHILD less than 10 years: 125 - 250 mg 8 hourly. CHILD less than 20 kg: 20 - 40 mg/kg/day in 3 - 4 divided doses |
| 85 | Amphotericin B 50 mg Injection (Conventional) | J02AA01-801-P40-01-XXX | A | Systemic fungal infections | None | ADULT: 0.25 mg/kg/day by IV infusion, gradually increase if tolerated to 1 mg/kg/day. Maximum in severe cases: 1.5 mg/kg daily or on alternate days. For neonates, lower doses are recommended |
| 86 | Ampicillin Sodium & Sulbactam Sodium 250 mg/5 ml Suspension | J01CR01-961-F21-01-XXX | A | Treatment of susceptible bacterial infections | None | ADULT: 375-750mg twice daily. CHILDREN (weight < 30kg): 25-50mg/kg/day in two divided doses. For children weighing 30kg and more, follow usual adult dose. |
| 87 | Ampicillin Sodium & Sulbactam Sodium 375 mg Tablet | J01CR01-961-T10-01-XXX | A/KK | Treatment of susceptible bacterial infections | None | ADULT: 375-750mg twice daily CHILDREN AND INFANTS: 25-50mg/kg/day in 2 divided doses, if ≥ 30kg use an adult dose |
| 88 | Ampicillin Sodium 1g & Sulbactam Sodium 500mg Injection | J01CR01-961-P40-02-XXX | A | Treatment of susceptible bacterial infections | None | ADULT: 1.5 - 12 g/day in divided doses 6 - 8 hourly. Maximum: 4 g Sulbactam. CHILD: 150-300 mg/kg/day 6 - 8 hourly. Prophylaxis of surgical infections: 1.5 - 3 g at induction of anaesthesia. May be repeated 6 - 8 hourly. NEONATES: First week of life, 75mg/kg/day in divided doses every 12 hour |
| 89 | Ampicillin Sodium 500 mg Injection | J01CA01-520-P40-01-XXX | B | Treatment of susceptible bacterial infections (non beta-lactamase-producing organisms); meningitis | None | 250 - 500 mg IM/IV every 4 - 6 hours. Maximum: 400 mg/kg/day. Meningitis: 2 g 6 hourly. CHILD: 150 mg/kg/daily IV in divided doses. Usual children dose less than 10 years, half adult dose |
| 90 | Ampicillin Sodium 500mg & Sulbactam Sodium 250mg Injection | J01CR01-961-P40-01-XXX | A | Treatment of susceptible bacterial infections | None | ADULT: 1.5 - 12 g/day in divided doses 6 - 8 hourly. Maximum: 4 g Sulbactam per day. CHILD: 150-300mg/kg/day 6 - 8 hourly. Prophylaxis: 1.5 -3 g at induction of anaesthesia. May be repeated 6 - 8 hourly |